FDA's Letter to Heron Therapeutics (HRTX) Over Sustol Approval

Go back to FDA's Letter to Heron Therapeutics (HRTX) Over Sustol Approval
HERON THERAPEUTICS (NASDAQ: HRTX) Delayed: 0.31 +0.01 (3.33%)
Previous Close $0.30    52 Week High $31.32 
Open $0.32    52 Week Low $13.95 
Day High $0.33    P/E N/A 
Day Low $0.31    EPS $-3.29 
Volume 3,137,766